Note*: This report requires 5-10 business days to complete.
DelveInsight’s “Duchenne Muscular Dystrophy - Market Insights, Epidemiology and Market Size Forecast-2020” Reports provides an overview of the disease and global market size of the Duchenne Muscular Dystrophy for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Duchenne Muscular Dystrophy from 2010-2020.Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. It affects approximately 1 in 3500 live male births throughout the world. There is no cure for DMD at this time, but there continues to be a tremendous amount of research taking place across the world. Researchers have made great advances in their knowledge of DMD and continue to search for a cure by new gene-based therapies such as conventional gene replacement strategies, RNA-based approaches, or cell-based gene therapy with a main focus on Duchenne muscular dystrophy (DMD).
Scope
• Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
• It also provides Market size of Duchenne Muscular Dystrophy for United States, EU5 and Japan from 2010 and forecasted Market size to 2020
'
Table of Contents
• Duchenne Muscular Dystrophy
• Disease overview:
• Pathophysiology:
• Symptoms of disease:
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• United States
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Duchenne Muscular Dystrophy Market
• Global Epidemiology of Duchenne Muscular Dystrophy Forecasted to 2020
• Global Market size (2011-2014)
• Global Forecasted Market size (2015-2020)
• Global Market Size by Geography
• Market size of US (2011-2014)
• Forecasted Market size of US (2015-2020)
• Market size of Europe
• Market size of Germany (2011-2014)
• Forecasted Market size of Germany (2015-2020)
• Market size of United Kingdom (2011-2014)
• Forecasted Market size of United Kingdom (2015-2020)
• Market size of France (2011-2014)
• Forecasted Market size of France (2015-2020)
• Market size of Italy (2011-2014)
• Forecasted Market size of Italy (2015-2020)
• Market size of Spain (2011-2014)
• Forecasted Market size of Spain (2015-2020)
• Market size of Japan (2011-2014)
• Forecasted Market Size of Japan (2015-2020)
• Market size of ROW (2011-2014)
• Forecasted Market size of ROW (2015-2020)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Duchenne Muscular Dystrophy Drug Sales (USD Millions), (2014-2020)
• Table 6: Global Epidemiology of Duchenne Muscular Dystrophy (2011-2020)
• Table 7: Duchenne Muscular Dystrophy Global Market Size (USD Millions), (2011-2014)
• Table 8: Duchenne Muscular Dystrophy Global Market Size (USD Millions), (2015-2020)
• Table 9: Duchenne Muscular Dystrophy US Market Size (USD Millions), (2011-2014)
• Table 10: Duchenne Muscular Dystrophy US Market Size (USD Millions), (2015-2020)
• Table 11: Duchenne Muscular Dystrophy United Kingdom Market Size (USD Millions), (2011-2014)
• Table 12: Duchenne Muscular Dystrophy Germany Market Size (USD Millions), (2015-2020)
• Table 13: Duchenne Muscular Dystrophy United Kingdom Market Size (USD Millions), (2011-2014)
• Table 14: Duchenne Muscular Dystrophy United Kingdom Market Size (USD Millions), (2015-2020)
• Table 15: Duchenne Muscular Dystrophy France Market Size (USD Millions), (2011-2014)
• Table 16: Duchenne Muscular Dystrophy France Market Size (USD Millions), (2015-2020)
• Table 17: Duchenne Muscular Dystrophy Italy Market Size (USD Millions), (2011-2014)
• Table 18: Duchenne Muscular Dystrophy Italy Market Size (USD Millions), (2015-2020)
• Table 19: Duchenne Muscular Dystrophy Spain Market Size (USD Millions), (2011-2014)
• Table 20: Duchenne Muscular Dystrophy Spain Market Size (USD Millions), (2015-2020)
• Table 21: Duchenne Muscular Dystrophy Japan Market Size (USD Millions), (2011-2014)
• Table 22: Duchenne Muscular Dystrophy Japan Market Size (USD Millions), (2015-2020)
• Table 23: Duchenne Muscular Dystrophy ROW Market Size (USD Millions), (2011-2014)
• Table 24: Duchenne Muscular Dystrophy ROW Market Size (USD Millions), (2015-2020)
List of Figures
• Figure 1: Duchenne Muscular Dystrophy Drug Sales (USD Millions), (2011-2014)
• Figure 2: Global Epidemiology of Duchenne Muscular Dystrophy (2011-2020)
• Figure 3: Duchenne Muscular Dystrophy Global Market Size (USD Millions), (2011-2014)
• Figure 4: Duchenne Muscular Dystrophy Global Market Size (USD Millions), (2015-2020)
• Figure 5: Duchenne Muscular Dystrophy US Market Size (USD Millions), (2011-2014)
• Figure 6: Duchenne Muscular Dystrophy US Market Size (USD Millions), (2015-2020)
• Figure 7: Duchenne Muscular Dystrophy Germany Market Size (USD Millions), (2011-2014)
• Figure 8: Duchenne Muscular Dystrophy Germany Market Size (USD Millions), (2015-2020)
• Figure 9: Duchenne Muscular Dystrophy United Kingdom Market Size (USD Millions), (2011-2014)
• Figure 10: Duchenne Muscular Dystrophy United Kingdom Market Size (USD Millions), (2015-2020)
• Figure 11: Duchenne Muscular Dystrophy France Market Size (USD Millions), (2011-2014)
• Figure 12: Duchenne Muscular Dystrophy France Market Size (USD Millions), (2015-2020)
• Figure 13: Duchenne Muscular Dystrophy Italy Market Size (USD Millions), (2011-2014)
• Figure 14: Duchenne Muscular Dystrophy Italy Market Size (USD Millions), (2015-2020)
• Figure 15: Duchenne Muscular Dystrophy Spain Market Size (USD Millions), (2011-2014)
• Figure 16: Duchenne Muscular Dystrophy Spain Market Size (USD Millions), (2015-2020)
• Figure 17: Duchenne Muscular Dystrophy Japan Market Size (USD Millions), (2011-2014)
• Figure 18: Duchenne Muscular Dystrophy Japan Market Size (USD Millions), (2015-2020)
• Figure 19: Duchenne Muscular Dystrophy ROW Market Size (USD Millions), (2011-2014)
• Figure 20: Duchenne Muscular Dystrophy ROW Market Size (USD Millions), (2015-2020)
